DMPE PEG Maleimide Conjugate (DMPE-PEG-Mal)

• Description:

  DMPE PEG Maleimide Conjugate (DMPE-PEG-Mal)_x000D_ Catalog number: B2013525_x000D_ Lot number: Batch Dependent_x000D_ Expiration Date: Batch dependent_x000D_ Amount: 25 mg_x000D_ Molecular Weight or Concentration: 5 kDa_x000D_ Supplied as: N/A_x000D_ Applications: molecular tool for various biochemical applications_x000D_ Storage: -20°C_x000D_ Keywords: DMPE PEG Maleimide_x000D_ Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ References:_x000D_ 1: Charbe NB, Amnerkar ND, Ramesh B, Tambuwala MM, Bakshi HA, Aljabali AAA, Khadse SC, Satheeshkumar R, Satija S, Metha M, Chellappan DK, Shrivastava G, Gupta G, Negi P, Dua K, Zacconi FC. Small interfering RNA for cancer treatment: overcoming hurdles in delivery Acta Pharm Sin B. 2020 Nov;10(11):2075-2109._x000D_ 2: Hadinoto K, Sundaresan A, Cheow WS. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review Eur J Pharm Biopharm. 2013 Nov;85(3 Pt A):427-43._x000D_ 3: Ishima Y, Yamazaki N, Chuang VTG, Shimizu T, Ando H, Ishida T. A Maleimide-Terminally Modified PEGylated Liposome Induced the Accelerated Blood Clearance Independent of the Production of Anti-PEG IgM Antibodies Biol Pharm Bull. 2022;45(10):1518-1524._x000D_ 4: Oswald M, Geissler S, Goepferich A. Determination of the activity of maleimide-functionalized phospholipids during preparation of liposomes Int J Pharm. 2016 Nov 30;514(1):93-102._x000D_ 5: Jin S, Li H, Xu Y. Preparation and Characterization of Trastuzumab Fab-Conjugated Liposomes (Immunoliposomes) Methods Mol Biol. 2023;2622:197-205._x000D_ 6: Yang Y, Feng Q, Ding C, Kang W, Xiao X, Yu Y, Zhou Q. Controllable Drug Delivery by Na+/K+ ATPase ÃŽ±1 Targeting Peptide Conjugated DSPE-PEG Nanocarriers for Breast Cancer Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211027898._x000D_ 7: Ma D, Huang C, Zheng J, Zhou W, Tang J, Chen W, Li J, Yang R. Azoreductase-Responsive Nanoprobe for Hypoxia-Induced Mitophagy Imaging Anal Chem. 2019 Jan 15;91(2):1360-1367._x000D_ 8: Xu M, Zhao M, Zheng D. Effect of IGF-1C domain-modified nanoparticles on renal ischemia-reperfusion injury in mice Ren Fail. 2022 Dec;44(1):1376-1387._x000D_ 9: Li H, Di J, Peng B, Xu Y, Zhang N. Surface Ligand Valency and Immunoliposome Binding: when More Is Not Always Better Pharm Res. 2021 Sep;38(9):1593-1600._x000D_ 10: KriviÄ€¡ H, Himbert S, Sun R, Feigis M, Rheinstädter MC. Erythro-PmBs: A Selective Polymyxin B Delivery System Using Antibody-Conjugated Hybrid Erythrocyte Liposomes ACS Infect Dis. 2022 Oct 14;8(10):2059-2072. _x000D_ _x000D_ Products Related to DMPE PEG Maleimide Conjugate (DMPE-PEG-Mal) can be found at Lipids

• Short Description:

  Catalog Number: B2013525 (25 mg)_x000D_ DMPE PEG Maleimide Conjugate (DMPE-PEG-Mal) is a high quality Pegylated phospholipids DMPE conjugated to Maleimide. This product has been used as molecular tool for various biochemical applications. It has also been used in a wide array of other chemical and immunological applications. Custom bulk amounts of this product are available upon request._x000D_ _x000D_

• Weight:

  0.15

• Length:

  2

• Width:

  0.5

• Height :

  0.5